IDRI, Wellcome Trust team for tuberculosis vaccine trial in South Africa

(Infectious Disease Research Institute) Today, the Infectious Disease Research Institute (IDRI) and Wellcome Trust announce the start of a Phase 2a trial in South Africa of IDRI's tuberculosis vaccine candidate, which has been shown to both prevent and treat TB in preclinical studies in animal models. The Wellcome Trust awarded IDRI a $5.8 million/£3.8 million grant to clinically assess the ability of IDRI's vaccine candidate to reduce TB recurrence after treatment.
Source: EurekAlert! - Infectious and Emerging Diseases - Category: Infectious Diseases Source Type: news